Healthcare providers’ practice protocols, strategies, and needed tools to address parental HPV vaccine hesitancy: An exploratory study

References

• Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. Oct 27 2011;365(17):1–11. doi:10.1056/NEJMoa1010971.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med. Feb 3 2011;364(5):401–11. doi:10.1056/NEJMoa0909537.
   PubMed Web of Science ®Google Scholar
• Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jiménez S, Schiller JT, Lowy DR, et al. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica vaccine trial. Lancet Oncol. 2011 Sep;12(9):862–70. doi:10.1016/s1470-2045(11)70213-3.
   PubMed Web of Science ®Google Scholar
• Herrero R, Quint W, Hildesheim A, Gonzalez, P, Struijk, L, Katki, HA, Porras, C, Schiffman, M, Rodriguez, AC, Solomon, D, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013;8(7):e68329. doi:10.1371/journal.pone.0068329.
   PubMed Web of Science ®Google Scholar
• FUTUREI/IIStudyGroup,Dillner J, Kjaer SK, Wheeler, CM, Sigurdsson, K, Iverson, OE, Hernandez-Avila, M, Perez, G, Brown, DR, Koutsky, LA, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. Jul 20 2010;341:c3493. doi:10.1136/bmj.c3493.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. HPV cancers are preventable. DHHS. Accessed September 22, 2022. https://www.cdc.gov/hpv/hcp/protecting-patients.html
   Google Scholar
• Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015 Jun;107(6):djv086. doi:10.1093/jnci/djv086.
   PubMedGoogle Scholar
• Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M. Human Papillomavirus–associated cancers — United States, 2008–2012. MMWR Morb Mortal Wkly Rep. Jul 8 2016;65(26):661–66. doi:10.15585/mmwr.mm6526a1.
   PubMedGoogle Scholar
• Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, Crowe SJ, Stokley S, Singleton JA. National vaccination coverage among adolescents aged 13–17 years — national immunization survey-teen, United States, 2021. MMWR Morb Mortal Wkly Rep. Sep 2 2022;71(35):1101–08. doi:10.15585/mmwr.mm7135a1.
   PubMed Web of Science ®Google Scholar
• Saxena K, Marden JR, Carias C, Bhatti, A, Patterson-Lomba, O, Gomez-Lievano, A, Yao, L, Chen, YT. Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States. Curr Med Res Opin. 2021;37(12):2077–87. [Accessed 2021 Dec 02]. doi:10.1080/03007995.2021.1981842.
   PubMed Web of Science ®Google Scholar
• Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Williams CL, Fredua B, McNamara LA, Stokley S, Singleton JA. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2020. MMWR Morb Mortal Wkly Rep. Sep 3 2021;70(35):1183–90. doi:10.15585/mmwr.mm7035a1.
   PubMed Web of Science ®Google Scholar
• Rositch AF, Liu T, Chao C, Moran M, Beavis AL. Levels of parental human papillomavirus vaccine hesitancy and their reasons for not intending to vaccinate: insights from the 2019 National Immunization Survey-Teen. J Adolesc Health. 2022 Jul;71(1):39–46. doi:10.1016/j.jadohealth.2022.01.223.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Albertin CS, Gurfinkel D, Saville AW, Vangala S, Rice JD, Helmkamp L, Zimet GD, Valderrama R, Breck A, et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine. Aug 27 2020;38(38):6027–37. doi:10.1016/j.vaccine.2020.06.074.
   PubMed Web of Science ®Google Scholar
• Tsui J, Martinez B, Shin MB, Allee-Munoz A, Rodriguez I, Navarro J, Thomas-Barrios KR, Kast WM, Baezconde-Garbanati L. Understanding medical mistrust and HPV vaccine hesitancy among multiethnic parents in Los Angeles. J Behav Med. Feb 2 2022;1–16. doi:10.1007/s10865-022-00283-9.
   PubMed Web of Science ®Google Scholar
• MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. Aug 14 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• McRee AL, Gilkey MB, Dempsey AF. HPV vaccine hesitancy: findings from a statewide survey of health care providers. J Pediatr Health Care. 2014 Nov-Dec;28(6):541–49. doi:10.1016/j.pedhc.2014.05.003.
   PubMed Web of Science ®Google Scholar
• Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn JA, Casler A, Salmon D, Walkosz B, Roetzheim RG, Zimet GD, et al. Missing the target for routine human papillomavirus vaccination: consistent and strong physician recommendations are lacking for 11- to 12-year-old males. Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435–46. doi:10.1158/1055-9965.Epi-15-1294.
   PubMed Web of Science ®Google Scholar
• Hopfer S, Wright ME, Pellman H, Wasserman R, Fiks AG. HPV vaccine recommendation profiles among a national network of pediatric practitioners: understanding contributors to parental vaccine hesitancy and acceptance. Hum Vaccin Immunother. 2019;15(7–8):1776–83. doi:10.1080/21645515.2018.1560771.
   PubMed Web of Science ®Google Scholar
• Edwards KM, Hackell JM. Countering vaccine hesitancy. Pediatrics. 2016 Sep;138(3). doi:10.1542/peds.2016-2146
   Web of Science ®Google Scholar
• Opel DJ, Zhou C, Robinson JD, Henrikson N, Lepere K, Mangione-Smith R, Taylor JA. Impact of childhood vaccine discussion format over time on immunization status. Acad Pediatr. 2018 May-Jun;18(4):430–36. doi:10.1016/j.acap.2017.12.009.
   PubMed Web of Science ®Google Scholar
• Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017 Jan;139(1). doi:10.1542/peds.2016-1764
   PubMed Web of Science ®Google Scholar
• Reno JE, O’Leary S, Garrett K, Pyrzanowski J, Lockhart S, Campagna E, Barnard J, Dempsey AF. Improving provider communication about HPV vaccines for vaccine-hesitant parents through the use of motivational interviewing. J Health Commun. 2018;23(4):313–20. doi:10.1080/10810730.2018.1442530.
   PubMed Web of Science ®Google Scholar
• Kornides ML, McRee AL, Gilkey MB. Parents who decline HPV vaccination: who later accepts and why? Acad Pediatr. 2018 Mar;18(2s):S37–s43. doi:10.1016/j.acap.2017.06.008.
   PubMed Web of Science ®Google Scholar
• Margolis MA, Brewer NT, Boynton MH, Lafata JE, Southwell BG, Gilkey MB. Provider response and follow-up to parental declination of HPV vaccination. Vaccine. Jan 21 2022;40(2):344–50. doi:10.1016/j.vaccine.2021.11.055.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1673–79. doi:10.1158/1055-9965.Epi-15-0326.
   PubMed Web of Science ®Google Scholar
• Ellingson MK, Bednarczyk RA, O’Leary ST, Schwartz JL, Shapiro ED, Niccolai LM. Understanding the factors influencing health care provider recommendations about adolescent vaccines: a proposed framework. J Behav Med. 2022 [Accessed 2022 Feb 22]. doi:10.1007/s10865-022-00296-4.
   PubMed Web of Science ®Google Scholar
• Cunningham-Erves J, Koyama T, Huang Y, Jones J, Wilkins CH, Harnack L, McAfee C, Hull PC. Providers’ perceptions of parental human papillomavirus vaccine hesitancy: cross-sectional study. JMIR Cancer. Jul 2 2019;5(2):e13832. doi:10.2196/13832.
   PubMed Web of Science ®Google Scholar
• Kempe A, Daley MF, McCauley MM, Crane LA, Suh CA, Kennedy AM, Basket MM, Stokley SK, Dong F, Babbel CI, et al. Prevalence of parental concerns about childhood vaccines: the experience of primary care physicians. Am J Prev Med. 2011 May;40(5):548–55. doi:10.1016/j.amepre.2010.12.025.
   PubMed Web of Science ®Google Scholar
• Williams JTB, O’Leary ST, Nussbaum AM. Caring for the vaccine-hesitant family: evidence-based alternatives to dismissal. J Pediatr. 2020 Sep;224:137–40. doi:10.1016/j.jpeds.2020.05.029.
   PubMed Web of Science ®Google Scholar
• Sturm L, Donahue K, Kasting M, Kulkarni A, Brewer NT, Zimet GD. Pediatrician-parent conversations about human papillomavirus vaccination: an analysis of audio recordings. J Adolesc Health. 2017 Aug;61(2):246–51. doi:10.1016/j.jadohealth.2017.02.006.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick DH, Burkman RT. Does standardization of care through clinical guidelines improve outcomes and reduce medical liability? Obstet Gynecol. 2010 Nov;116(5):1022–26. doi:10.1097/AOG.0b013e3181f97c62.
   PubMed Web of Science ®Google Scholar
• Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. Feb 20 1999;318(7182):527–30. doi:10.1136/bmj.318.7182.527.
   PubMedGoogle Scholar
• Heymann T. Clinical protocols are key to quality health care delivery. Int J Health Care Qual Assur. 1994;7(7):14–17. doi:10.1108/09526869410074702.
   PubMedGoogle Scholar
• Bundy DG, Persing NM, Solomon BS, King TM, Murakami PN, Thompson RE, Engineer LD, Lehmann CU, Miller MR. Improving immunization delivery using an electronic health record: the ImmProve project. Acad Pediatr. 2013 Sep-Oct;13(5):458–65. doi:10.1016/j.acap.2013.03.004.
   PubMed Web of Science ®Google Scholar
• Mayne SL, du Rivage NE, Feemster KA, Localio AR, Grundmeier RW, Fiks AG, duRivage NE. Effect of decision support on missed opportunities for human papillomavirus vaccination. Am J Prev Med. 2014 Dec;47(6):734–44. doi:10.1016/j.amepre.2014.08.010.
   PubMed Web of Science ®Google Scholar
• Fontenot HB, Kornides ML, McRee AL, Gilkey MB. Importance of a team approach to recommending the human papillomavirus vaccination. J Am Assoc Nurse Pract. 2018 Jul;30(7):368–72. doi:10.1097/jxx.0000000000000064.
   PubMed Web of Science ®Google Scholar
• Tsui J, Vincent A, Anuforo B, Btoush R, Crabtree BF. Understanding primary care physician perspectives on recommending HPV vaccination and addressing vaccine hesitancy. Hum Vaccin Immunother. Jul 3 2021;17(7):1961–67. doi:10.1080/21645515.2020.1854603
   PubMed Web of Science ®Google Scholar
• DeJonckheere M, Vaughn LM. Semistructured interviewing in primary care research: a balance of relationship and rigour. Fam Med Community Health. 2019;7(2):e000057. doi:10.1136/fmch-2018-000057.
   PubMed Web of Science ®Google Scholar
• Creswell J. Qualitative inquiry and research design: chooosing among five traditions. Newbury Park, California: Sage Publications; 1998.
   Google Scholar
• Gilkey MB, Magnus BE, Reiter PL, McRee AL, Dempsey AF, Brewer NT. The vaccination confidence scale: a brief measure of parents’ vaccination beliefs. Vaccine. Oct 29 2014;32(47):6259–65. doi:10.1016/j.vaccine.2014.09.007
   PubMed Web of Science ®Google Scholar
• Creswell JW, Plano-Clark VL. Designing and conducting mixed method research, 3rd ed. Newbury Park, California: Sage Publications; 2011.
   Google Scholar
• Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015 Sep;42(5):533–44. doi:10.1007/s10488-013-0528-y.
   PubMed Web of Science ®Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006;18(1):59–82. [Accessed 2006 Feb 01]. doi:10.1177/1525822X05279903.
   Web of Science ®Google Scholar
• Hagaman AK, Wutich A. How many interviews are enough to identify metathemes in multisited and cross-cultural research? Another perspective on guest, Bunce, and Johnson’s (2006) landmark study. Field Methods. 2016;29(1):23–41. [Accessed 2017 Feb 01]. doi:10.1177/1525822X16640447.
   Web of Science ®Google Scholar
• Morse JM Designing funded qualitative research. In: Denzin NK, and Lincoln YS, Handbook of qualitative research. Newbury Park, California: Newbury Park; 1994. pp. 230–35.
   Google Scholar
• Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res. 2017 Mar;27(4):591–608. doi:10.1177/1049732316665344.
   PubMed Web of Science ®Google Scholar
• Goddard AF, Patel M. The changing face of medical professionalism and the impact of COVID-19. Lancet. Mar 13 2021;397(10278):950–52. doi:10.1016/s0140-6736(21)00436-0
   PubMed Web of Science ®Google Scholar
• Borgiel AE, Dunn EV, Lamont CT, MACDONALD PJ, EVENSEN MK, BASS MJ, SPASOFF RA, WILLIAMS J. Recruiting family physicians as participants in research. Fam Pract. 1989 Sep;6(3):168–72. doi:10.1093/fampra/6.3.168.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019 Jul;95:103208. doi:10.1016/j.jbi.2019.103208.
   PubMed Web of Science ®Google Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57. doi:10.1093/intqhc/mzm042.
   PubMed Web of Science ®Google Scholar
• Morse JM. Critical analysis of strategies for determining rigor in qualitative inquiry. Qual Health Res. 2015 Sep;25(9):1212–22. doi:10.1177/1049732315588501.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Bednarczyk RA, Gerend MA, Kornides ML, Perkins RB, Saslow D, Sienko J, Zimet GD, Brewer NT. Getting human papillomavirus vaccination back on track: protecting our national investment in human papillomavirus vaccination in the COVID-19 era. J Adolesc Health. 2020 Nov;67(5):633–34. doi:10.1016/j.jadohealth.2020.08.013.
   PubMed Web of Science ®Google Scholar
• Olagoke AA, Carnahan LR, Olagoke O, Molina Y. Shared determinants for human papillomavirus and COVID-19 vaccination intention: an opportunity for resource consolidation. Am J Health Promot. 2022 Mar;36(3):506–09. doi:10.1177/08901171211053933.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. Feb 24 2016;34(9):1187–92. doi:10.1016/j.vaccine.2016.01.023.
   PubMed Web of Science ®Google Scholar
• O’Leary S, Nyquist A. Why AAP recommends initiating HPV vaccination as early as age 9. Accessed July 16, 2022. https://www.aappublications.org/news/2019/10/04/hpv100419.
   Google Scholar
• Kong WY, Huang Q, Thompson P, Grabert BK, Brewer NT, Gilkey MB. Recommending human papillomavirus vaccination at age 9: a national survey of primary care professionals. Acad Pediatr. 2022 May-Jun;22(4):573–80. doi:10.1016/j.acap.2022.01.008.
   PubMed Web of Science ®Google Scholar
• Lin C, Mullen J, Smith D, Kotarba M, Kaplan SJ, Tu P. Healthcare providers’ vaccine perceptions, hesitancy, and recommendation to patients: a systematic review. Vaccines (Basel). Jul 1 2021;9(7). doi:10.3390/vaccines9070713.
   Web of Science ®Google Scholar
• Biancarelli DL, Drainoni ML, Perkins RB. Provider experience recommending hpv vaccination before age 11 years. J Pediatr. 2020 Feb;217:92–97. doi:10.1016/j.jpeds.2019.10.025.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, McRee AL. Provider communication about HPV vaccination: a systematic review. Hum Vaccin Immunother. Jun 2 2016;12(6):1454–68. doi:10.1080/21645515.2015.1129090
   PubMed Web of Science ®Google Scholar
• Perkins RB, Fisher-Borne M, Brewer NT. Engaging parents around vaccine confidence: proceedings from the national HPV vaccination roundtable meetings. Hum Vaccin Immunother. 2019;15(7–8):1639–40. doi:10.1080/21645515.2018.1520592.
   PubMed Web of Science ®Google Scholar
• Sundstrom B, Cartmell KB, White AA, Russo N, Well H, Pierce JY, Brandt HM, Roberts JR, Ford ME. HPV vaccination champions: evaluating a technology-mediated intervention for parents. Front Digit Health. 2021;3:636161. doi:10.3389/fdgth.2021.636161.
   PubMedGoogle Scholar
• Karafillakis E, Peretti-Watel P, Verger P, Chantler T, Larson HJ. The role of maturity in adolescent decision-making around HPV vaccination in France. Vaccine. Sep 24 2021;39(40):5741–47. doi:10.1016/j.vaccine.2021.08.096.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Laz TH, Hirth JM, McGrath CJ, Rahman M. Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age. Hum Vaccin Immunother. 2014;10(7):1807–11. doi:10.4161/hv.28779.
   PubMed Web of Science ®Google Scholar
• Gamble HL, Klosky JL, Parra GR, Randolph ME. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol. 2010 Aug;35(7):704–15. doi:10.1093/jpepsy/jsp108.
   PubMed Web of Science ®Google Scholar
• Alexander AB, Stupiansky NW, Ott MA, Herbenick D, Reece M, Zimet GD. Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr. 2012;12(1):192. [Accessed 2012 Dec 14]. doi:10.1186/1471-2431-12-192.
   PubMedGoogle Scholar
• Herman R, McNutt LA, Mehta M, Salmon DA, Bednarczyk RA, Shaw J. Vaccination perspectives among adolescents and their desired role in the decision-making process. Hum Vaccin Immunother. 2019;15(7–8):1752–59. doi:10.1080/21645515.2019.1571891.
   PubMed Web of Science ®Google Scholar